Division of Clinical Immunology and Rheumatology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294.
Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294.
J Immunol. 2018 Oct 15;201(8):2203-2208. doi: 10.4049/jimmunol.1800791. Epub 2018 Sep 10.
In systemic lupus erythematosus (SLE), type I IFNs promote induction of type I IFN-stimulated genes (ISG) and can drive B cells to produce autoantibodies. Little is known about the expression of distinct type I IFNs in lupus, particularly high-affinity IFN-β. Single-cell analyses of transitional B cells isolated from SLE patients revealed distinct B cell subpopulations, including type I IFN producers, IFN responders, and mixed IFN producer/responder clusters. Anti-Ig plus TLR3 stimulation of SLE B cells induced release of bioactive type I IFNs that could stimulate HEK-Blue cells. Increased levels of IFN-β were detected in circulating B cells from SLE patients compared with controls and were significantly higher in African American patients with renal disease and in patients with autoantibodies. Together, the results identify type I IFN-producing and -responding subpopulations within the SLE B cell compartment and suggest that some patients may benefit from specific targeting of IFN-β.
在系统性红斑狼疮(SLE)中,I 型干扰素可促进 I 型干扰素刺激基因(ISG)的诱导,并可驱动 B 细胞产生自身抗体。关于狼疮中不同类型 I 型干扰素的表达,特别是高亲和力 IFN-β,人们知之甚少。从 SLE 患者中分离出的过渡 B 细胞的单细胞分析显示出不同的 B 细胞亚群,包括 I 型 IFN 产生细胞、IFN 反应细胞和混合 IFN 产生/反应细胞簇。SLE B 细胞的抗 Ig 加 TLR3 刺激诱导释放具有生物活性的 I 型 IFN,可刺激 HEK-Blue 细胞。与对照组相比,SLE 患者循环 B 细胞中 IFN-β 水平升高,且在有肾脏疾病的非裔美国患者和自身抗体阳性患者中更高。总之,这些结果确定了 SLE B 细胞群中 I 型 IFN 产生和反应的亚群,并表明某些患者可能受益于 IFN-β 的特异性靶向治疗。